BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 28333214)

  • 1. 'Forever Young'-Testosterone replacement therapy: a blockbuster drug despite flabby evidence and broken promises.
    Busnelli A; Somigliana E; Vercellini P
    Hum Reprod; 2017 Apr; 32(4):719-724. PubMed ID: 28333214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late-life onset hypogonadism: a review.
    Bassil N; Morley JE
    Clin Geriatr Med; 2010 May; 26(2):197-222. PubMed ID: 20497841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EMAS position statement: Testosterone replacement therapy in the aging male‏.
    Dimopoulou C; Ceausu I; Depypere H; Lambrinoudaki I; Mueck A; Pérez-López FR; Rees M; van der Schouw YT; Senturk LM; Simonsini T; Stevenson JC; Stute P; Goulis DG
    Maturitas; 2016 Feb; 84():94-9. PubMed ID: 26614257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Testosterone Replacement Therapy on Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis.
    Kohn TP; Mata DA; Ramasamy R; Lipshultz LI
    Eur Urol; 2016 Jun; 69(6):1083-90. PubMed ID: 26874809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EMAS position statement: Testosterone replacement therapy in older men.
    Kanakis GA; Pofi R; Goulis DG; Isidori AM; Armeni E; Erel CT; Fistonić I; Hillard T; Hirschberg AL; Meczekalski B; Mendoza N; Mueck AO; Simoncini T; Stute P; van Dijken D; Rees M; Lambrinoudaki I
    Maturitas; 2023 Dec; 178():107854. PubMed ID: 37845136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
    Coward RM; Simhan J; Carson CC
    BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone therapy in older men with late-onset hypogonadism: a counter-rationale.
    Basaria S
    Endocr Pract; 2013; 19(5):853-63. PubMed ID: 24014017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone replacement therapy for late-onset hypogonadism: current trends in Korea.
    Ko YH; Kim JJ
    Asian J Androl; 2011 Jul; 13(4):563-8. PubMed ID: 21572448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marketing and Testosterone Treatment in the USA: A Systematic Review.
    Bandari J; Ayyash OM; Emery SL; Wessel CB; Davies BJ
    Eur Urol Focus; 2017 Oct; 3(4-5):395-402. PubMed ID: 29174614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale.
    Lunenfeld B; Saad F; Hoesl CE
    Aging Male; 2005 Jun; 8(2):59-74. PubMed ID: 16096160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone supplementation does not worsen lower urinary tract symptoms.
    Pearl JA; Berhanu D; François N; Masson P; Zargaroff S; Cashy J; McVary KT
    J Urol; 2013 Nov; 190(5):1828-33. PubMed ID: 23764078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypotestosteronaemia in the aging male: should we treat it?
    Christe N; Meier CA
    Swiss Med Wkly; 2015; 145():w14216. PubMed ID: 26599486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone Replacement Therapy and Mortality in Older Men.
    Hackett GI
    Drug Saf; 2016 Feb; 39(2):117-30. PubMed ID: 26482385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone Replacement Therapy and the Risk of Prostate Cancer in Men With Late-Onset Hypogonadism.
    Santella C; Renoux C; Yin H; Yu OHY; Azoulay L
    Am J Epidemiol; 2019 Sep; 188(9):1666-1673. PubMed ID: 31145457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone replacement therapy for late onset hypogonadism: what is the risk of inducing prostate cancer?
    Gould DC; Kirby RS
    Prostate Cancer Prostatic Dis; 2006; 9(1):14-8. PubMed ID: 16264770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.
    Marks LS; Mazer NA; Mostaghel E; Hess DL; Dorey FJ; Epstein JI; Veltri RW; Makarov DV; Partin AW; Bostwick DG; Macairan ML; Nelson PS
    JAMA; 2006 Nov; 296(19):2351-61. PubMed ID: 17105798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone supplementation therapy for older men: potential benefits and risks.
    Gruenewald DA; Matsumoto AM
    J Am Geriatr Soc; 2003 Jan; 51(1):101-15; discussion 115. PubMed ID: 12534854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of testosterone replacement therapy withdrawal and re-treatment in hypogonadal elderly men upon obesity, voiding function and prostate safety parameters.
    Yassin A; Nettleship JE; Talib RA; Almehmadi Y; Doros G
    Aging Male; 2016; 19(1):64-9. PubMed ID: 26742589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. State-of-the-Art: a Review of Cardiovascular Effects of Testosterone Replacement Therapy in Adult Males.
    Elsherbiny A; Tricomi M; Bhatt D; Dandapantula HK
    Curr Cardiol Rep; 2017 Apr; 19(4):35. PubMed ID: 28361372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of the "aging male"].
    Diemer T; Hauck EW; Rohde V; Weidner W
    Urologe A; 2005 Oct; 44(10):1173-8. PubMed ID: 16151757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.